Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus

Cell Transplantation

Volumn 17, Issue 12, 2008, Pages 1295-1304

  Estrada, Esteban J ^a   Valacchi, Fabian ^a   Nicora, Eduardo ^a   Brieva, Sergio ^a   Esteve, Claudio ^a   Echevarria, Laura ^a   Froud, Tatiana ^b   Bernetti, Karina ^b   Cayetano, Shari Messinger ^b   Velazquez, Omaida ^e   Alejandro, Rodolfo ^b   Ricordi, Camillo ^b,c,d,f  

^a Stem Cell Argentina   (Argentina)

^b UNIVERSITY OF MIAMI   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF MIAMI HOSPITAL   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Autologous transplant; Hyperbaric oxygen; Stem cell; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; ROSIGLITAZONE;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; DISEASE DURATION; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERBARIC OXYGEN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANIMALS; BLOOD GLUCOSE; BONE MARROW CELLS; C-PEPTIDE; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERBARIC OXYGENATION; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 62549123720     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908787648119     Document Type: Article

References (55)

1. Abidia, A.; Laden, G.; Kuhan, G.; Johnson, B. F.; Wilkinson, A. R.; Renwick, P. M.; Masson, E. A.; McCollum, P. T. The role of hyperbaric oxygen therapy in ischemic diabetic lower extremity ulcers: A double-blind randomized controlled trial. Eur. J. Vasc. Endovasc. Surg. 25: 513-518; 2003.
2. Alvarez, S. S.; Jimínez, L. M.; Murillo, A. Z.; Gómez, I. G.; Ligero, J. M.; Gómez-Pineda, A.; Rollán-Landeras, E.; Cuevas, P.; Jara-Albarrán, A. A new approach for bone marrow-derived stem cells intrapancreatic autotrans-plantation in diabetic rats. Microsurgery 26(7):539-542; 2006.
3. Aronson, D. Hyperglycemia and the pathobiology of diabetic complications. Adv. Cardiol. 45:1-16; 2008.
4. Avogaro, A.; Fadini, G. P.; Gallo, A.; Pagnin, E.; de Kreutzenberg, S. Endothelial dysfunction in type 2 diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 16:39-45; 2006.
5. Baharvand, H.; Jafary, H.; Massumi, M.; Ashtiani, S. K. Generation of insulin-secreting cells from human embryonic stem cells. Dev. Growth Differ. 48(5):323-332; 2006.
6. Bonner-Weir, S.; Taneja, M.; Weir, G. C.; Tatarkiewicz, K.; Song, K. H.; Sharma, A.; O'Neil, J. J. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 97(14):7999-8004; 2000.
7. Burt, R. K.; Cohen, B.; Rose, J. Hematopoietic stem cell transplantation for multiple sclerosis. Arch. Neurol. 62(6): 860-864; 2005.
8. Burt, R. K.; Marmont, A.; Oyama, Y. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum. 54(12):3750-3760; 2006.
9. Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213(2):341-347; 2007.
10. Choi, Y.; Ta, M.; Atouf, F.; Lumelsky, N. Adult pancreas generates multipotent stem cells and pancreatic and nonpancreatic progeny. Stem Cells 22(6): 1070-1084; 2004.
11. Domínguez-Bendala, J.; Ricordi, C. Stem cell therapies in reparative medicine. Cell Transplant. 12(4):329-334; 2003.
12. Donath, M. Y.; Ehses, J. A.; Maedler, K.; Schumann, D. M.; Ellingsgaard, H.; Eppler, E.; Reinecke, M. Mechanisms of β-cell death in type 2 diabetes. Diabetes 54:108-113; 2005.
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26:5-20; 2003.
14. Fadini, G. P.; Sartore, S.; Schiavon, M.; Albiero, M.; Baesso, I.; Cabrelle, A.; Agostini, C.; Avogaro, A. Diabetes impairs progenitor cell mobilization after hindlimb is-chemia-reperfusion injury in rats. Diabetologia 49(12): 3075-3084; 2006.
15. Fang, B.; Song, Y. P.; Liao, L. M.; Han, Q.; Zhao, R. C. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant. 38(5):389-390; 2006.
16. Fu, M. X.; Wells-Knecht, K. J.; Blackledge, J. A.; Lyons, T. J.; Thorpe, S. R.; Baynes, J. W. Glycation, glycoxida-tion, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43(5):676-683; 1994.
17. Galiñanes, M.; Loubani, M.; Davies, J.; Chin, D,; Pasi, J.; Bell, P. R. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant. 13(1):7-13; 2004.
18. Gallagher, K. A.; Jun Liu, Z.; Xiao, M.; Chen, H.; Goldstein, L. J.; Buerk, D. G.; Nedeau, A.; Thorn, S. R.; Velazquez, O. C. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alfa. J. Clin. Invest. 117(5): 1249-1259; 2007.
19. Gangaram-Panday, S. T.; Faas, M. M.; de Vos, P. Towards stem-cell therapy in the endocrine pancreas. Trends Mol. Med. 13(4):164-173; 2007.
20. Garcia-Olmo, D.; Garcia-Arranz, M.; Herreros, D.; Pascual, I.; Peiro, C.; Rodriguez-Montes, J. A. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum 48(7):1416-1423; 2005.
21. Gill, A. L.; Bell, C. A. N. Hyperbaric oxygen in uses, mechanisms of action and outcomes. QJM 97:385-395; 2004.
22. Goldstein, L. J.; Gallagher, K. A.; Bauer, S. M.; Bauer, R. J.; Baireddy, V.; Liu, Z. J.; Buerk, D. G.; Thorn, S. R.; Velazquez, O. C. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells 24(10):2309-2318; 2006.
23. Hao, E.; Tyrberg, B.; Itkin-Ansari, P.; Lakey, J. R.; Geron, I.; Monosov, E. Z.; Barcova, M.; Mercola, M.; Levine, F. β-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat. Med. 12(3):310-316; 2006.
24. Hess, D.; Li, L.; Martin, M.; Sakano, S.; Hill, D.; Strutt, B.; Thyssen, S.; Gray, D. A.; Bhatia, M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21(7):763-770; 2003.
25. Hori, Y.; Rulifson, I. C.; Tsai, B. C.; Heit, J. J.; Cahoy, J. D.; Kim, S. K. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc. Natl. Acad. Sci. USA 99(25): 16105-16110; 2002.
26. Kim, D.; Gu, Y.; Ishii, M.; Fujimiya, M.; Qi, M.; Nakamura, N.; Yoshikawa, T.; Sumi, S.; Inoue, K. In vivo functioning and transplantable mature pancreatic islet-like cell clusters differentiated from embryonic stem cell. Pancreas 27(2):34-41; 2003.
27. King, G. L.; Brownlee, M. The cellular and molecular mechanisms of diabetic complications. Endocrinol. Metab. Clin. North Am. 25(2):255-270; 1996.
28. Kuki, S.; Imanishi, T.; Kobayashi, K.; Matsuo, Y.; Obana, M.; Akasaka, T. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ. J. 70:1076-1081; 2006.
29. Larsen, C. M.; Faulenbach, M.; Vaag, A.; Volund, A.; Ehses, J. A.; Seifert, B.; Mandrup-Poulsen, T.; Donath, M. Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356(15):1517-1526; 2007.
30. Leahy, J. L. Pathogenesis of type 2 diabetes mellitus. Arch. Med. Res. 36(3):197-209; 2005.
31. Lee, R. H.; Seo, M. J.; Reger, R. L.; Spees, J. L.; Pulin, A. A.; Olson, S. D.; Prockop, D. J. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 103(46): 17438-17443; 2006.
32. Lipsett, M. A.; Castellarin, M. L.; Rosenberg, L. Acinar plasticity: Development of a novel in vitro model to study human acinar-to-duct-to-islet differentiation. Pancreas 34(4): 452-457; 2007.
33. Lipsett, M.; Finegood, D. T. β-cell neogenesis during prolonged hyperglycemia in rats. Diabetes 51(6):1834-1841; 2002.
34. Maedler, K.; Spinas, G. A.; Lehmann, R.; Sergeev, P.; Weber, M.; Fontana, A.; Kaiser, N.; Donath, M. Y. Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50(8):1683-1690; 2001.
35. Marchetti, P.; Del Prato, S.; Lupi, R.; Del Guerra, S. The pancreatic beta-cell in human type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 16 (l):3-6; 2006.
36. Martin, B. C.; Warrant, J. H.; Krolewski, A. S.; Bergman, R. N.; Soeldner, J. S.; Kahn, C. R. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study. Lancet 340(8825):925-929; 1992.
37. Mathews, V.; Hanson, P. T.; Ford, E.; Fujita, J.; Polonsky, K. S.; Graubert, T. A. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 53:91-98; 2004.
38. Miyata, T.; Inagi, R.; Iida, Y.; Sato, M.; Yamada, N.; Oda, O.; Maeda, K.; Seo, H. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J. Clin. Invest. 93(2):521-528; 1994.
39. Poitout, V.; Robertson, R. P. Secondary β-cell failure in type 2 diabetes a convergence of glucotoxicity and lipo-toxicity. Endocrinology 143(2):339-342; 2002.
40. Prentki, M.; Joly, E.; El-Assaad, W.; Roduit, R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes. Diabetes 51(3):405-413; 2002.
41. Prentki, M.; Nolan, C. J. Islet β cell failure in type 2 diabetes. J. Clin. Invest. 116(7):1802-1812; 2006.
42. Ramiya, V. K.; Maraist, M.; Arfors, K. E.; Schatz, D. A.; Peck, A. B.; Cornelius, J. G. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med. 6(3):278-282; 2000.
43. Ramos, G. A.; Hare, J. M. Cardiac cell-based therapy: Cell types and mechanisms of actions. Cell Transplant. 16(9):951-961; 2007.
44. Ringden, O.; Uzunel, M.; Rasmusson, I. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81(10):1390-1397; 2006.
45. Robertson, R.; Zhou, H.; Zhang, T.; Harmon, J. S. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem. Biophys. 48(2-3): 139-146; 2007.
46. Robertson, R. P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet β cells in diabetes. J. Biol. Chem. 279(41):42351-42354; 2004.
47. Schuleri, K. H.; Boyle, A. J.; Hare, J. M. Mesenchymal stem cells for cardiac regenerative therapy. Handb. Exp. Pharmacol. 180:195-218; 2007.
48. Segal, M. S.; Shah, R.; Afzal, A.; Perrault, C. M.; Chang, K.; Schuler, A.; Beem, E.; Shaw, L. C.; Li Calzi, S.; Harrison, J. K. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 55:102-109; 2006.
49. Tepper, O. M.; Galiano, R. D.; Capla, J. M.; Kalka, C.; Gagne, P. J.; Jacobowitz, G. R.; Levine, J. P.; Gurtner, G. C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786; 2002.
50. Thorn, S. R. Hyperbaric-oxygen therapy for acute carbon monoxide poisoning. N. Engl. J. Med. 347:1105-1106; 2002.
51. Thorn, S. R.; Bhopale, V. M.; Velazquez, O. C.; Goldstein, L. J.; Thorn, L. H.; Buerk, D. G. Stem cell mobilization by hyperbaric oxygen. Am. J. Physiol. Heart Circ. Physiol. 290(4):1378-1386; 2006.
52. Urbán, V.; Kiss, J.; Kovács, J.; Gócza, E.; Vas, V.; Monostori, E.; Uher, F. Mesenchymal stem cells cooperate with bone marrow cells in therapy at diabetes. Stem Cells 26:244-253; 2008.
53. Voltarelli, J. C.; Couri, C. E.; Stracieri, A. B. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297(14):1568-1576; 2007.
54. Yang, L.; Li, S.; Hatch, H.; Ahrens, K.; Cornelius, J. G.; Petersen, B. E.; Peck, A. B. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. USA 99(12): 8078-8083; 2002.
55. Zhao, M.; Amiel, S. A.; Christie, M. R.; Muiesan, P.; Srinivasan, P.; Littlejohn, W.; Rela, M.; Arno, M.; Heaton, N.; Huang, G. C. Evidence for the presence of stem cell-like progenitor cells in human adult pancreas. J. Endocrinol. 195(3):407-414; 2007.